May 1, 2013 | The Motley Fool
Big Pharma's Kickback Conundrum
Leo is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.
Report: Pfizer Inc.'s Celebrex and Bextra safety lawsuit continues
A U.S. District Judge in New York has scheduled a pre-trial conference for a shareholding lawsuit alleging top Pfizer Inc.
Pfizer Loses Bid to Have Celebrex Investor Suits Tossed
Pfizer Inc. , the world's biggest drugmaker, must face investors' claims that company executives misled them about the prospects for arthritis drugs Celebrex and Bextra , a judge ruled.
Pfizer fails to end lawsuit over Bextra, Celebrex safety
Pfizer Inc has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the cardiovascular risks associated with its Bextra and Celebrex pain-relieving drugs.
Pfizer fails to end lawsuit over Bextra, Celebrex safety
ROB Insight is The Globe and Mail's exclusive feature led by a team of award-winning editors and writers who provide you with in-depth analysis on breaking business news and the issues that matter most.